Lysosomal membrane permeabilization and cell death
Top Cited Papers
Abstract
Lysosomes are membrane‐enclosed organelles that mediate the intracellular degradation of macromolecules. They play an essential role in calcium regulation and have emerged as key signaling hubs in controlling the nutrient response. Maintaining lysosomal integrity and function is therefore crucial for cellular homeostasis. Different forms of stress can induce lysosomal membrane permeabilization (LMP), resulting in the translocation to the cytoplasm of intralysosomal components, such as cathepsins, inducing lysosomal‐dependent cell death (LDCD). Here, we review recent advances that have furthered our understanding of the molecular mechanisms of LMP and the methods used to detect it. We discuss several endolysosomal damage‐response mechanisms that mediate the repair or elimination of compromised lysosomes and summarize the role of LMP and cathepsins in LDCD and other cell death pathways. Finally, with the emergence of lysosomes as promising therapeutic targets for several human diseases, we review a variety of therapeutic strategies that seek to either destabilize lysosomes or to maintain, enhance or restore lysosomal function.Keywords
Funding Information
- Comunidad de Madrid (2017/BMD‐3813)
This publication has 147 references indexed in Scilit:
- HSP70 inhibition by 2-phenylethynesulfonamide induces lysosomal cathepsin D release and immunogenic cell death in primary effusion lymphomaCell Death & Disease, 2013
- Transcription factor EB (TFEB) is a new therapeutic target for Pompe diseaseEMBO Molecular Medicine, 2013
- Cationic Amphiphilic Drugs Cause a Marked Expansion of Apparent Lysosomal Volume: Implications for an Intracellular Distribution-Based Drug InteractionMolecular Pharmaceutics, 2012
- Endosome maturationThe EMBO Journal, 2011
- Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012Cell Death & Differentiation, 2011
- Attenuation of the Lysosomal Death Pathway by Lysosomal Cholesterol AccumulationThe American Journal of Pathology, 2011
- Termination of autophagy and reformation of lysosomes regulated by mTORNature, 2010
- NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystalsNature, 2010
- Hsp70 stabilizes lysosomes and reverts Niemann–Pick disease-associated lysosomal pathologyNature, 2010
- The NALP3 inflammasome is involved in the innate immune response to amyloid-βNature Immunology, 2008